Camber Pharma Launches Generic Protonix®
Piscataway, NJ, January 22, 2015– Camber Pharmaceuticals announces that it has launched Pantoprazole Sodium Delayed-Release Tablets USP. The drug is the generic version of Protonix® tablets. Pantoprazole is used to treat gastro esophageal reflux disease, (GERD) and damage to the esophagus.
Pantoprazole is available from Camber in 20 and 40mg’s and comes in 90 count bottles.
If you would like more information about this topic, please contact Megan Becker at 732.529.0436 or email at [email protected].
Recent articles
- New to Camber’s Portfolio: Olmesartan medoxomil, Amlodipine and Hydrochlorothiazide Tablets
- Camber Pharmaceuticals Honored as Second Merit Finalist at 2026 DIANA Awards
- Camber Launches Nitazoxanide Tablets
- Cisatracurium Besylate Injection, USP Added to Camber’s Portfolio
- Camber Welcomes Summer 2026 Intern Class
- Camber Launches 5 Generics in May






